Journal of the Formosan Medical Association = Taiwan yi zhi · 2025
Unveiling the characteristics of lobar-predominant cerebral microbleeds in Fabry disease.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hsieh Pei-Feng, Lin Po-Yu, Lee Ni-Chung, Chen Chih-Hao, Sung Pi-Shan, Juang Jyh-Ming, Chen Ya-Fang, Jeng Jiann-Shing, Chien Yin-Hsiu, Tang Sung-Chun
Аннотация
BACKGROUND AND OBJECTIVES: Fabry disease (FD) is a multisystem lysosomal storage disorder with central nervous system and cardiac involvement. Although FD is associated with varying severity of white matter hyperintensity (WMH) on brain magnetic resonance imaging (MRI), cerebral microbleeds (CMBs) have been less studied. This study examined CMBs in FD and identified their association with clinical parameters.
METHODS: We retrospectively enrolled patients with FD followed up at two medical centers in Taiwan. All underwent brain MRI, including susceptibility-weighted imaging. CMB distribution was determined using the Microbleed Anatomical Rating Scale framework.
RESULTS: Among the 26 enrolled patients (mean age: 55.8 years, 92 % men), 22 received regular enzyme replacement therapy before MRI. The median [interquartile] Fazekas score for periventricular and deep white matter was 1 [0,1] and 1 [1,1], respectively. CMBs were detected in 16 (62 %) patients, with 94 % (n = 15) exhibiting lobar involvement, either in a mixed pattern (n = 8) or a strictly lobar distribution (n = 7). The lobar CMB + had significantly higher plasma lyso-Gb3 levels (6.37 [4.58-18.20] vs. 3.4 [2.25-5.05] ng/mL, p = 0.021), greater left ventricular posterior wall thickness (LVPWd; 14.4 ± 2.4 vs. 11.8 ± 2.7 mm, p = 0.019), and a higher prevalence of dipstick proteinuria (73 % vs. 18 %, p = 0.015). After adjustment for variables, LVPWd remained independently associated with lobar CMBs (odds ratio: 1.83, 95 % CI: 1.01-3.34).
CONCLUSION: Lobar-predominant CMBs were common in our FD cohort and were associated with cardiomyopathy but not with cerebral small vessel disease imaging markers. Further research is needed to explore the causal relationship.
METHODS: We retrospectively enrolled patients with FD followed up at two medical centers in Taiwan. All underwent brain MRI, including susceptibility-weighted imaging. CMB distribution was determined using the Microbleed Anatomical Rating Scale framework.
RESULTS: Among the 26 enrolled patients (mean age: 55.8 years, 92 % men), 22 received regular enzyme replacement therapy before MRI. The median [interquartile] Fazekas score for periventricular and deep white matter was 1 [0,1] and 1 [1,1], respectively. CMBs were detected in 16 (62 %) patients, with 94 % (n = 15) exhibiting lobar involvement, either in a mixed pattern (n = 8) or a strictly lobar distribution (n = 7). The lobar CMB + had significantly higher plasma lyso-Gb3 levels (6.37 [4.58-18.20] vs. 3.4 [2.25-5.05] ng/mL, p = 0.021), greater left ventricular posterior wall thickness (LVPWd; 14.4 ± 2.4 vs. 11.8 ± 2.7 mm, p = 0.019), and a higher prevalence of dipstick proteinuria (73 % vs. 18 %, p = 0.015). After adjustment for variables, LVPWd remained independently associated with lobar CMBs (odds ratio: 1.83, 95 % CI: 1.01-3.34).
CONCLUSION: Lobar-predominant CMBs were common in our FD cohort and were associated with cardiomyopathy but not with cerebral small vessel disease imaging markers. Further research is needed to explore the causal relationship.